Background: This research aimed to explore the efficacy and safety of electroacupuncture in promoting the recovery of postoperative gastrointestinal function and to discuss the potential mechanism on the basis of heart rate variability (HRV). Patients and Methods: This was a randomized controlled study. Postoperative patients with gastric cancer received either electroacupuncture (EA) or sham electroacupuncture (SEA) 2 h after surgery and on the morning of the first 2 days after surgery, with each session lasting 30 min. The acupoints, treatment timepoints, and treatment durations in the SEA group were kept consistent with those in the EA group, but the intervention was SEA. Both groups were equipped with artificial intelligence HRV monitoring devices to monitor perioperative HRV and continuous bowel sound auscultation recorders to monitor perioperative bowel sound recovery in real time. Gastrointestinal function recovery indicators, HRV indicators, inflammatory markers, the incidence of postoperative complications, and adverse events were analyzed. Results: There was no statistically significant difference (P > 0.05) in baseline. First flatus time, first oral feeding time, intestinal function recovery time, and length of postoperative hospitalization of EA group were better than those of the SEA group, (P < 0.05). On day 3 after surgery, in EA group, C-reactive protein, interleukin-1 beta (IL-1β) were lower than those in SEA group (P < 0.05). HRV indicators such as standard deviation of the average NN intervals, percentage of successive RR intervals that differ by more than 50 ms (PNN50), and high frequency were higher in EA group than those in SEA group (P < 0.05). Conclusions: EA can safely and effectively promote gastrointestinal function rehabilitation in postoperative patients with gastric cancer, whose mechanism may be associated with higher tension in the vagus nerve, affected by EA.
2 March 2018 in World Journal of Surgical Oncology
During the last decade, total laparoscopic and laparoscopic-assisted distal gastrectomy for gastric cancer patients has been developed as alternatives to open resection. In recent years, this minimally invasive surgery has been extended using robotic-assisted surgery. Here, we report a surgical intervention using a Da Vinci surgical robot in which a lower two-third stomach resection with subsequent Billroth II gastrojejunostomy was performed. The patient was a 53-year-old male with complete situs inversus gastric cancer who had received 2 cycles of neo-adjuvant oxaliplatin combined with S-1 medication. The operation took 3 h in total without complications. The amount of bleeding was about 50 mL, and on day 5 after the operation, the patient was discharged. This is the first report of a successful robot-assisted gastric cancer resection of advanced gastric cancer in a patient with the anatomical abnormality of situs inversus totalis.
Background: Circulating tumor DNA (ctDNA)‐based minimal residual disease (MRD) detection, which can identify disease relapse ahead of radiological imaging, has shown promising performance. The objective of this study was to develop and validate OriMIRACLE S (Minimal Residual Circulating Nucleic Acid Longitudinal Detection in Solid Tumor), a highly sensitive and specific tumor‐informed assay for MRD detection.Methods: Tumor‐specific somatic single nucleotide variants (SNVs) were identified via whole exome sequencing of tumor tissue and matched germline DNA. Clonal SNVs were selected using the OriSelector algorithm for patient‐specific, multiplex PCR‐based NGS assays in MRD detection. Plasma‐free DNA from patients with gastrointestinal tumors prior to and following an operation, and during monitoring, were ultradeep sequenced.Results: The detection of three positive sites was sufficient to achieve nearly 100% overall sample level sensitivity and specificity and was determined by calculating binomial probability based on customized panels containing 21 to 30 variants. A total of 127 patients with gastrointestinal tumors were enrolled in our study. Preoperatively, MRD was positive in 18 of 26 patients (69.23%). Following surgery, MRD was positive in 24 of 82 patients (29.27%). The positivity rate for MRD was 33.33% (n = 18) for gastric adenocarcinoma and 32.26% (n = 62) for colorectal cancer. Twenty (20) of 59 patients (34.48%) experienced a change in MRD status over the monitoring period. Patients 8 and 31 responded to 3 cycles of systemic therapy, after which levels for all ctDNA dropped below the detection limit. Patient 53 was an example of using MRD to predict tumor metastasis. Patient 55 showed a weak response to treatments first and respond to new systemic therapy after tumor progression.Conclusion: Our study identified a sensitive and specific clinical detection method for low frequency ctDNA, and explored the detection performance of this technology in gastrointestinal tumors.
16 September 2025 in International Journal of Surgery
Background: Early identification of patients at risk of developing postoperative sleep disorders (PSD), which is a common complication after surgery, is an essential step in reducing surgical stress and is an important part of enhanced recovery after surgery. Objective: In this study, we used a smart patch to explore heart rate variability (HRV), reflecting autonomic nervous system regulation, as potential PSD digital biomarkers and develop a prognostic model for the early identification of PSD. Methods: We assessed 120 h of continuous HRV in a separate sample of 51 patients who underwent radical surgery for gastrointestinal cancer with and without PSD. Results: By analyzing the 120-h HRV data of the two groups, we found that patients with PSD exhibited lower parasympathetic tone and longer dysregulated autonomic circadian rhythms. The area under the curve of the risk factor prediction model established by HRV parameters was 0.815; sensitivity was 0.909; specificity was 0.621; and the Youden index was 0.530. Conclusion: This research supports the utility of HRV as a non-invasive diagnostic tool, emphasizing its importance in perioperative management of sleep quality and potential to expand its use during the perioperative period.
Background: The inflammation and nutrition status are crucial factors influencing the outcome of patients with gastric cancer. This study aims to investigate the prognostic value of the preoperative prognostic nutritional index (PNI) in patients with stage I–III gastric cancer undergoing robotic radical gastrectomy combined with Enhanced Recovery after Surgery (ERAS), and further to create a clinical prognosis prediction model.Study: 525 patients with stage I–III gastric cancer who underwent ERAS combined with RRG from July 2010 to June 2018 were included in this work, and were divided randomly into training and validating groups in a 7-to-3 ratio. The association between PNI and overall survival (OS) was assessed by Kaplan-Meier analysis and the log-rank test. Independent risk factors impacting postoperative survival were analyzed with the Cox proportional hazards regression model. A nomogram for predicting OS was constructed based on multivariate analysis, and its predictive performance was evaluated using Harrell's concordance index (C-index), calibration plots, ROC curve, decision curve analysis (DCA), and time-dependent ROC curve analysis.Results: Survival analyses revealed the presence of a significant correlation between low preoperative PNI and shortened postoperative survival (P = 0.001). According to multivariate analysis, postoperative complications (P < 0.001), pTNM stage (II: P = 0.007; III: P < 0.001), PNI (P = 0.048) and lymph node ratio (LNR) (P = 0.003) were independent prognostic factors in patients undergoing ERAS combined with RRG. The nomogram constructed based on PNI, pTNM stage, complications, and LNR was superior to the pTNM stage model in terms of predictive performance. The C-indexes of the nomogram model were respectively 0.765 and 0.754 in the training and testing set, while AUC values for 1-year, 3-year, and 5-year OS were 0.68, 0.71, and 0.74 in the training set and 0.60, 0.67, and 0.72 in the validation set.Conclusion: Preoperative PNI is an independent prognostic factor for patients with stage I–III gastric cancer undergoing ERAS combined with robotic radical gastrectomy. Based on PNI, we constructed a nomogram for predicting postoperative outcomes of gastric cancer patients, which might be utilized clinically.
Objective: Gastroblastoma is an extremely rare gastric tumor. Its pathogenesis remains unclear and there is a lack of specific clinical symptoms. The aim of this paper is to report a case of gastroblastoma and provide references for the diagnosis, treatment, and prognosis of this disease.Methods: The diagnosis and treatment of a 51-year-old female patient with gastroblastoma were retrospectively reported. Analyzing this case by combining the clinical data such as imaging and pathological results of patients with the relevant literature.Results: The patient’s chief complaint was the presence of melena persisted for over two weeks. Abdominal contrast-enhanced CT showed gastric antral nodules, and micro-probe endoscopic ultrasonography was considered as “gastric antral protruding lesions”. The initial diagnosis of “gastric stromal tumor” was made after admission, and surgical treatment was performed on September 23, 2021. Postoperative pathology showed that gastric mixed epithelial and stromal tumor, combined with immunohistochemical staining, was suggestive of gastroblastoma. No signs of tumor recurrence or metastasis were observed during the 2-year follow-up.Conclusion: Combined with the existing literature reports, the incidence of gastroblastoma is mainly higher in young men, and the predilection site is gastric antrum. The biological behavior of the tumor tends to be indolent, and the prognosis of most cases is favorable. However, due to the extremely small number of cases, this conclusion still needs a large number of cases and follow-up data to support. Postoperative pathological and immunohistochemical examination results are the only methods for definite diagnosis at present, and surgery is the first choice for treatment.